IP Library Granted Patent US 8,093,235
Granted Patent B2
US 8,093,235 · App. 12/258,208 · Granted Jan 10, 2012

Macrocyclic compounds which stabilize G-Quadruplex DNA and RNA

Assignees: Rutgers, The State University of New Jersey; University of Medicine and Dentistry of New Jersey
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,093,235
App. No.
12/258,208
Granted
Jan 10, 2012
Kind
B2
Abstract

The invention provides compounds of formula I: wherein A, B, D, E, R 1 , R 2 , R 3 , R 4 , R 5 , X, and ----- have any values defined herein, as well as salts thereof. The compounds have activity as G-quadruplex DNA stabilizers and as anti-proliferative agents.

Claims (24)

1. A compound of formula I:

wherein:

each B and E is independently —C(═O)NH—CH(R a )— or —C(═O)—NH—C(═O)—, and each A and D is independently a group of the formula:

each R 1 , R 2 , R 3 , R 4 , and R 5 is independently H, (C 1 -C 6 )alkyl, or (C 1 -C 6 )alkoxy, wherein each (C 1 -C 6 )alkyl and (C 1 -C 6 )alkoxy is optionally substituted with OH, (C 1 -C 6 )alkoxy, (C 1 -C 6 )alkylthio, aryl, NR c R d , or —C(═O)NR c R d ;

each X is independently NH, S, or O;

each Z is independently N or CH;

the bond represented by ----- is a single or a double bond;

each R a is independently H, aryl, or (C 1 -C 6 )alkyl that is optionally substituted with OH, (C 1 -C 6 )alkoxy, (C 1 -C 6 )alkylthio, aryl, NR e R f , or —C(═O)NR e R f ;

each R c and R d is independently H or (C 1 -C 6 )alkyl; or R c and R d together with the nitrogen to which they are attached form a pyrrolidino, piperidino, piperazino, morpholino, thiomorpholino, or azepino ring; and

each R e and R f is independently H or (C 1 -C 6 )alkyl; or R e and R f together with the nitrogen to which they are attached form a pyrrolidino, piperidino, piperazino, morpholino, thiomorpholino, or azepino ring;

or a salt thereof;

provided the compound of formula I is not telomestatin or dehydrotelomestatin.

2. The compound of claim 1 which is a compound of formula (II):

or a pharmaceutically acceptable salt thereof.

3. A pharmaceutical composition comprising a compound of formula I as described in claim 1 ; or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable carrier.

4. A method to stabilize G-quadruplex DNA comprising contacting the G-quadruplex DNA with a compound of formula I as described in claim 1 , or a salt thereof.

5. The compound of claim 1 which is a compound of the following formula:

or a salt thereof.

6. A compound of the following formula 15, 16, 17, or 50:

or a salt thereof.

7. The compound of claim 1 which is a compound of the following formula:

or a salt thereof.

8. The compound of claim 1 which is a compound of the following formula 219 or 220:

or a salt thereof.

Assignments (4)
CONFIRMATORY LICENSE Recorded Feb 4, 2022
From: RUTGERS, THE STATE UNIV. OF N.J.
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 058884/0310 →
CONFIRMATORY LICENSE Recorded Apr 12, 2010
From: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024216/0346 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 24, 2009
From: LIU, LEROY F.
To: UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY
Reel/Frame 023561/0881 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 24, 2009
From: LAVOIE, EDMOND J.; RICE, JOSEPH E.
To: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
Reel/Frame 023561/0933 →
Continuity (3)
Continuation PCTUS2007009862 · Apr 24, 2007
Provisional Application 60794525 · Apr 25, 2006
Related Publication 20090156627A1 · Jun 18, 2009